Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Synovitis, Pigmented Villonodular × pexidartinib × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Synovitis, Pigmented Villonodular 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Melanoma 1 Hodgkin Disease 1 Hemangiosarcoma 1 Giant Cell Tumor of Tendon Sheath 1 Breast Neoplasms 1

Interventions

nilotinib 2 pexidartinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04703322 2026-03-04

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Daiichi Sankyo

Phase 2 Active not recruiting

9 enrolled 10 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡